Release Date: 29/03/10 09:20 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 116.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%